curasan AG, Germany announced that it has received news that the Japanese Pharmaceutical and Medical Devices Agency (PMA) has approved Osbone for distribution to the local market. The approval process, which is particularly complicated in Japan, was successfully completed within the expected timeframe. By this, the Japanese sales partner of curasan AG, Hakuho Co. Ltd., can offer another product in addition to Cerasorb M granules. Osbone is a purely synthetic material and thus free of risks for allergies and disease transmission. It consists of hydroxyapatite, which has a particularly high porosity, comparable to human bone. Osbone also has a high volume stability and can therefore be loaded immediately. This property is an important criterion for positioning in the market. Competitor products also have this stability, but consist of animal hydroxyapatite.